Skip to main content
Log in

Dobutamine, isoprenaline and dopamine in patients after open heart surgery

Catecholamines after open-heart surgery

  • Original Articles
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Dobutamine, a new synthetic catecholamine, has been developed as a more specific inotrope and is reported to have less effect on heart rate and peripheral vascular resistance than other catecholamines. Reports of its effects after cardiotomy have cast doubt on this idea. We have compared the haemodynamic effects of dobutamine with isoprenaline (Group I) and with dopamine (Group II) in early postcardiotomy patients. In both groups a dose response curve was evaluated (dopamine and dobutamine were given at 1.25, 2.5, 5.0 and 10.0 μg/kg/min; isoprenaline at 0.005, 0.01, 0.02 and 0.04 μg/kg/min). In Group I both drugs caused significant increases in cardiac index at the highest dose level only. At that level isoprenaline was associated with a significantly higher heart rate than dobutamine and a significantly lower systemic vascular resistance. Similarly, in Group II, both drugs caused significant increases in the cardiac index only at the highest dose level. However, the heart rate at this dose was significantly higher with dobutamine. Dopamine caused no changes in heart rate at any dose level. Neither drug was associated with any alteration of systemic vascular resistance. No changes in stroke volume, left atrial pressure or pulmonary vascular resistance were found in either group. The rise in cardiac output was caused mainly by tachycardia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Andy JJ, Cury CL, Ali N, Mehrotra PP (1977) Cardiovascular effects of dobutamine in severe congestive heart failure. Am Heart J 94:175–182

    PubMed  Google Scholar 

  2. Dijkema FK, Elzinga G (1973) Integrator for aortic and pulmonary artery flow signals with automatic zero adjustment and beat-to-beat mean flow computation. Cardiovasc Res 7:572–576

    PubMed  Google Scholar 

  3. Dollery CT, Follath F, Lewis GRJ (1975) Cardiovascular effects of dobutamine. Proc Br Pharmacol Soc, London C 20

  4. Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1086–1121

    Google Scholar 

  5. Innes IR, Nickerson M (1975) In: Goodman LS, Gilman A (eds) Isoproterenol toxicity and side effects in pharmacological basis of therapeutics (5th edn). Mac Millan, New York, p 494

    Google Scholar 

  6. Jewitt D, Mitchell A, Birkhead J, Dollery CT (1974) Clinical cardiovascular pharmacology of dobutamine. Lancet 2:363–367

    PubMed  Google Scholar 

  7. Kersting F, Follath F, Moulds R, Mucklow J, McCloy R, Sheares J, Dollery C (1976) A comparision of cardiovascular effects of dobutamine and isoprenaline after open heart surgery. Br Heart J 38:622–626

    PubMed  Google Scholar 

  8. Leier CV, Heban PT, Huss P, Bush CA, Lewis RP (1978) Comparative systemic and regional haemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58:466–475

    PubMed  Google Scholar 

  9. O'Kane H (1978) The comparative effects of dobutamine, isoprenaline and dopamine in post-operative cardiac surgical patients. Proc Eur Dobutamine Symposium, Glynne A, Lucas RA (eds) London, p 19

  10. Sakamoto T, Yamada T (1977) Haemodynamic effects of dobutamine in patients following open heart surgery. Circulation 55:525–532

    PubMed  Google Scholar 

  11. Steen PA, Tinker JH, Pluth JR, Barnhorst DA, Tarhan S (1978) Efficacy of dopamine, dobutamine and epinephrine during emergence from cardiopulmonary bypass in man. Circulation 57:378–384

    PubMed  Google Scholar 

  12. Tinker JH, Tarhan S, White RD, Pluth JR, Barnhorst DA (1976) Dobutamine for inotropic support during emergence from cardiopulmonary bypass. Anesthesiology 44:281–286

    PubMed  Google Scholar 

  13. Tuttle RR, Mills J (1973) Dobutamine — Development of a new catecholamine to selectively increase cardiac contractility. Circ Res 36:185–196

    Google Scholar 

  14. Williams BT, Rickards AF, Chamberlain JH (1975) Cardiac output and its derivatives using an implantable electromagnetic flow probe and intracardiac manometers. In: Longmore DB (ed) The current status of cardiac surgery. Medical and Technical Publishers, Lancashire, p 347

    Google Scholar 

  15. Winer BJ (1971) Statistical principles in experimental design, (2nd edn). McGraw-Hill-Kogakusha Limited, London, p 201

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chamberlain, J.H., Pepper, J.R. & Yates, A.K. Dobutamine, isoprenaline and dopamine in patients after open heart surgery. Intensive Care Med 7, 5–10 (1980). https://doi.org/10.1007/BF01692914

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01692914

Key words

Navigation